Sign inGet started

Lynch Casey

Insider CIK 1770783 · CRTX Chief Executive Officer, Director · LBPH Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0212,500— $00SEC↗
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0222,500— $00SEC↗
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0214,428— $00SEC↗
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2024-05-232024-05-2422,500— $022,500SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2023-05-252023-05-2612,500— $012,500SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2022-05-242022-05-3112,367— $012,367SEC↗
CRTX Cortexyme, Inc. A Award deriv2022-01-032022-01-05440,000— $0440,000SEC↗
CRTX Cortexyme, Inc. M Exercise deriv2021-11-182021-11-1960,000— $023,159SEC↗
CRTX Cortexyme, Inc. M Exercise2021-11-182021-11-1960,000$0.46 $27.6K109,895SEC↗
CRTX Cortexyme, Inc. S Sale2021-05-102021-05-12183$36.73 $6.7K978,774SEC↗
CRTX Cortexyme, Inc. S Sale2021-05-102021-05-126,315$35.81 $226.1K978,957SEC↗
CRTX Cortexyme, Inc. S Sale2021-05-102021-05-129,918$34.89 $346.0K985,272SEC↗
CRTX Cortexyme, Inc. S Sale2021-05-102021-05-1213,584$33.75 $458.5K995,190SEC↗
CRTX Cortexyme, Inc. S Sale2021-03-222021-03-2318,089$35.85 $648.5K1,009,474SEC↗
CRTX Cortexyme, Inc. S Sale2021-03-222021-03-23300$36.58 $11.0K1,009,174SEC↗
CRTX Cortexyme, Inc. S Sale2021-03-222021-03-23400$36.60 $14.6K1,008,774SEC↗
CRTX Cortexyme, Inc. S Sale2021-03-222021-03-2311,211$35.10 $393.5K1,027,563SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2021-03-112021-03-1114,428— $014,428SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2021-03-112021-03-1112,367— $012,367SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-032021-02-03400$37.39 $15.0K1,058,374SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-032021-02-031,600$38.64 $61.8K1,056,774SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-032021-02-03856$39.82 $34.1K1,055,918SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-032021-02-032,000$40.84 $81.7K1,053,918SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-032021-02-033,100$41.91 $129.9K1,050,818SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-032021-02-031,512$43.10 $65.2K1,049,306SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-032021-02-031,900$44.22 $84.0K1,047,406SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-032021-02-038,032$45.00 $361.4K1,039,374SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-032021-02-03600$45.73 $27.4K1,038,774SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-022021-02-035,071$36.75 $186.4K1,058,774SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-022021-02-0314,929$36.02 $537.7K1,063,845SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-012021-02-03100$38.28 $3.8K1,079,145SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-012021-02-034,686$34.60 $162.1K1,094,088SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-012021-02-033,100$35.59 $110.3K1,090,988SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-012021-02-037,460$36.56 $272.7K1,083,528SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-012021-02-034,283$37.68 $161.4K1,079,245SEC↗
CRTX Cortexyme, Inc. S Sale2021-02-012021-02-03371$39.23 $14.6K1,078,774SEC↗
CRTX Cortexyme, Inc. A Award deriv2020-12-112020-12-15175,000— $0175,000SEC↗
CRTX Cortexyme, Inc. A Award deriv2020-12-112020-12-15175,000— $0175,000SEC↗
CRTX Cortexyme, Inc. A Award deriv2020-02-062020-02-10175,000— $0175,000SEC↗